Novel Inflammatory Biomarkers in Cardiovascular Therapeutics

Author(s): Vicky Tsigkou, Gerasimos Siasos, Evangelos Oikonomou, Marina Zaromitidou, George Latsios, Manolis Vavuranakis, Spyridon Deftereos, Michael W. Cleman, Eleni Kokkou, Maria Limberi, Stathis Dimitropoulos, Thodoris Zografos, Smaragdi Marinaki, Christodoulos Stefanadis, Dimitris Tousoulis

Journal Name: Current Medicinal Chemistry

Volume 22 , Issue 23 , 2015

  Journal Home
Translate in Chinese
Become EABM
Become Reviewer
Call for Editor


Inflammation has been established as an important determinant of cardiovascular disease progression. Currently, clinical examination, laboratory and imaging tests are invaluable for the diagnosis, prognosis and disease monitoring. Novel inflammatory biomarkers are also used to better restratify patients in risk groups but their potential to guide treatment decisions and management of patients has not been extensively evaluated. Therefore, in this review article we present the most recent data concerning the use of inflammatory biomarkers in cardiovascular therapeutics.

Keywords: Atherosclerosis, biomarkers, cardiovascular diseases, coronary artery disease, heart failure, hypertension, inflammation, peripheral artery disease, stroke.

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2015
Published on: 18 August, 2015
Page: [2773 - 2785]
Pages: 13
DOI: 10.2174/0929867322666150429110124
Price: $65

Article Metrics

PDF: 36